Compare TIL & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIL | PHUN |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 42.6M |
| IPO Year | 2021 | 2016 |
| Metric | TIL | PHUN |
|---|---|---|
| Price | $6.90 | $1.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 58.7K | ★ 65.5K |
| Earning Date | 11-20-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 6.06 | ★ 39.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $30,883,000.00 |
| Revenue This Year | N/A | $37.21 |
| Revenue Next Year | N/A | $1,931.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.57 |
| 52 Week Low | $5.56 | $1.56 |
| 52 Week High | $16.00 | $2.40 |
| Indicator | TIL | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 25.76 |
| Support Level | $5.56 | $1.62 |
| Resistance Level | $7.75 | $2.12 |
| Average True Range (ATR) | 0.43 | 0.07 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 81.79 | 12.48 |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.